[Clinical manifestations of lymphatic bancroftian filariasis].
Identifieur interne : 006690 ( Ncbi/Curation ); précédent : 006689; suivant : 006691[Clinical manifestations of lymphatic bancroftian filariasis].
Auteurs : G. Dreyer ; A. Coutinho ; R. AlbuquerqueSource :
- AMB : revista da Associacao Medica Brasileira [ 0102-843X ]
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Filariose lymphatique.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Diéthylcarbamazine, Filariose lymphatique.
- Animaux, Filariose lymphatique, Humains, Wuchereria bancrofti.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Diethylcarbamazine.
- complications : Elephantiasis, Filarial.
- drug therapy : Elephantiasis, Filarial.
- immunology : Elephantiasis, Filarial.
- transmission : Elephantiasis, Filarial.
- Animals, Humans, Wuchereria bancrofti.
Abstract
A review of clinical manifestations of bancroftian filariasis, based on the literature and in the authors' experience, suggests a general classification in to six groups: 1) Normal endemics; 2) Individuals bearing microfilaremia; 3) Acute manifestations; 4) Chronic manifestations; 5) Tropical Pulmonary Eosinophilia; 6) Controversial forms. An overview on diagnostic procedures and the immunologic relationship between host and parasite was made in each group. Final considerations about treatment was also considered.
PubMed: 2486416
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005F34
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :005F34
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :005F34
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :006690
Links to Exploration step
pubmed:2486416Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Clinical manifestations of lymphatic bancroftian filariasis].</title><author><name sortKey="Dreyer, G" sort="Dreyer, G" uniqKey="Dreyer G" first="G" last="Dreyer">G. Dreyer</name></author><author><name sortKey="Coutinho, A" sort="Coutinho, A" uniqKey="Coutinho A" first="A" last="Coutinho">A. Coutinho</name></author><author><name sortKey="Albuquerque, R" sort="Albuquerque, R" uniqKey="Albuquerque R" first="R" last="Albuquerque">R. Albuquerque</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1989 Oct-Dec</MedlineDate></PubDate></date><idno type="RBID">pubmed:2486416</idno><idno type="pmid">2486416</idno><idno type="wicri:Area/PubMed/Corpus">005F34</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005F34</idno><idno type="wicri:Area/PubMed/Curation">005F34</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005F34</idno><idno type="wicri:Area/PubMed/Checkpoint">005F34</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005F34</idno><idno type="wicri:Area/Ncbi/Merge">006690</idno><idno type="wicri:Area/Ncbi/Curation">006690</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Clinical manifestations of lymphatic bancroftian filariasis].</title><author><name sortKey="Dreyer, G" sort="Dreyer, G" uniqKey="Dreyer G" first="G" last="Dreyer">G. Dreyer</name></author><author><name sortKey="Coutinho, A" sort="Coutinho, A" uniqKey="Coutinho A" first="A" last="Coutinho">A. Coutinho</name></author><author><name sortKey="Albuquerque, R" sort="Albuquerque, R" uniqKey="Albuquerque R" first="R" last="Albuquerque">R. Albuquerque</name></author></analytic><series><title level="j">AMB : revista da Associacao Medica Brasileira</title><idno type="ISSN">0102-843X</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Diethylcarbamazine (therapeutic use)</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (immunology)</term><term>Elephantiasis, Filarial (transmission)</term><term>Humans</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (immunologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (transmission)</term><term>Humains</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Filariose lymphatique</term><term>Humains</term><term>Wuchereria bancrofti</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A review of clinical manifestations of bancroftian filariasis, based on the literature and in the authors' experience, suggests a general classification in to six groups: 1) Normal endemics; 2) Individuals bearing microfilaremia; 3) Acute manifestations; 4) Chronic manifestations; 5) Tropical Pulmonary Eosinophilia; 6) Controversial forms. An overview on diagnostic procedures and the immunologic relationship between host and parasite was made in each group. Final considerations about treatment was also considered.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006690 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 006690 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:2486416
|texte= [Clinical manifestations of lymphatic bancroftian filariasis].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:2486416" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |